Copyright Reports & Markets. All rights reserved.

Global Binge Eating Disorder Drug Market Research Report 2021

Request for Sample of this report
Buy now

1 Binge Eating Disorder Drug Market Overview

  • 1.1 Product Overview and Scope of Binge Eating Disorder Drug
  • 1.2 Binge Eating Disorder Drug Segment by Type
    • 1.2.1 Global Binge Eating Disorder Drug Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Antidepressants
    • 1.2.3 Anticonvulsants
    • 1.2.4 Anti-obesity Medications
  • 1.3 Binge Eating Disorder Drug Segment by Application
    • 1.3.1 Binge Eating Disorder Drug Sales Comparison by Application: (2021-2027)
    • 1.3.2 Retail Pharmacies
    • 1.3.3 Hospital Pharmacies
    • 1.3.4 Online Pharmacies
  • 1.4 Global Binge Eating Disorder Drug Market Size Estimates and Forecasts
    • 1.4.1 Global Binge Eating Disorder Drug Revenue 2016-2027
    • 1.4.2 Global Binge Eating Disorder Drug Sales 2016-2027
    • 1.4.3 Binge Eating Disorder Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Binge Eating Disorder Drug Market Competition by Manufacturers

  • 2.1 Global Binge Eating Disorder Drug Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Binge Eating Disorder Drug Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Binge Eating Disorder Drug Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Binge Eating Disorder Drug Manufacturing Sites, Area Served, Product Type
  • 2.5 Binge Eating Disorder Drug Market Competitive Situation and Trends
    • 2.5.1 Binge Eating Disorder Drug Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Binge Eating Disorder Drug Players Market Share by Revenue
    • 2.5.3 Global Binge Eating Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Binge Eating Disorder Drug Retrospective Market Scenario by Region

  • 3.1 Global Binge Eating Disorder Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Binge Eating Disorder Drug Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Binge Eating Disorder Drug Market Facts & Figures by Country
    • 3.3.1 North America Binge Eating Disorder Drug Sales by Country
    • 3.3.2 North America Binge Eating Disorder Drug Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Binge Eating Disorder Drug Market Facts & Figures by Country
    • 3.4.1 Europe Binge Eating Disorder Drug Sales by Country
    • 3.4.2 Europe Binge Eating Disorder Drug Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Binge Eating Disorder Drug Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Binge Eating Disorder Drug Sales by Region
    • 3.5.2 Asia Pacific Binge Eating Disorder Drug Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Binge Eating Disorder Drug Market Facts & Figures by Country
    • 3.6.1 Latin America Binge Eating Disorder Drug Sales by Country
    • 3.6.2 Latin America Binge Eating Disorder Drug Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Binge Eating Disorder Drug Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Binge Eating Disorder Drug Sales by Country
    • 3.7.2 Middle East and Africa Binge Eating Disorder Drug Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Binge Eating Disorder Drug Historic Market Analysis by Type

  • 4.1 Global Binge Eating Disorder Drug Sales Market Share by Type (2016-2021)
  • 4.2 Global Binge Eating Disorder Drug Revenue Market Share by Type (2016-2021)
  • 4.3 Global Binge Eating Disorder Drug Price by Type (2016-2021)

5 Global Binge Eating Disorder Drug Historic Market Analysis by Application

  • 5.1 Global Binge Eating Disorder Drug Sales Market Share by Application (2016-2021)
  • 5.2 Global Binge Eating Disorder Drug Revenue Market Share by Application (2016-2021)
  • 5.3 Global Binge Eating Disorder Drug Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Roche
    • 6.1.1 Roche Corporation Information
    • 6.1.2 Roche Description and Business Overview
    • 6.1.3 Roche Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Roche Product Portfolio
    • 6.1.5 Roche Recent Developments/Updates
  • 6.2 Chronos Therapeutics
    • 6.2.1 Chronos Therapeutics Corporation Information
    • 6.2.2 Chronos Therapeutics Description and Business Overview
    • 6.2.3 Chronos Therapeutics Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Chronos Therapeutics Product Portfolio
    • 6.2.5 Chronos Therapeutics Recent Developments/Updates
  • 6.3 Heptares
    • 6.3.1 Heptares Corporation Information
    • 6.3.2 Heptares Description and Business Overview
    • 6.3.3 Heptares Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Heptares Product Portfolio
    • 6.3.5 Heptares Recent Developments/Updates
  • 6.4 Novo Nordisk
    • 6.4.1 Novo Nordisk Corporation Information
    • 6.4.2 Novo Nordisk Description and Business Overview
    • 6.4.3 Novo Nordisk Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Novo Nordisk Product Portfolio
    • 6.4.5 Novo Nordisk Recent Developments/Updates
  • 6.5 Omeros Corp
    • 6.5.1 Omeros Corp Corporation Information
    • 6.5.2 Omeros Corp Description and Business Overview
    • 6.5.3 Omeros Corp Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Omeros Corp Product Portfolio
    • 6.5.5 Omeros Corp Recent Developments/Updates
  • 6.6 Sunovion Pharmaceuticals
    • 6.6.1 Sunovion Pharmaceuticals Corporation Information
    • 6.6.2 Sunovion Pharmaceuticals Description and Business Overview
    • 6.6.3 Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Sunovion Pharmaceuticals Product Portfolio
    • 6.6.5 Sunovion Pharmaceuticals Recent Developments/Updates
  • 6.7 Opiant Pharmaceuticals
    • 6.6.1 Opiant Pharmaceuticals Corporation Information
    • 6.6.2 Opiant Pharmaceuticals Description and Business Overview
    • 6.6.3 Opiant Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Opiant Pharmaceuticals Product Portfolio
    • 6.7.5 Opiant Pharmaceuticals Recent Developments/Updates

7 Binge Eating Disorder Drug Manufacturing Cost Analysis

  • 7.1 Binge Eating Disorder Drug Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Binge Eating Disorder Drug
  • 7.4 Binge Eating Disorder Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Binge Eating Disorder Drug Distributors List
  • 8.3 Binge Eating Disorder Drug Customers

9 Binge Eating Disorder Drug Market Dynamics

  • 9.1 Binge Eating Disorder Drug Industry Trends
  • 9.2 Binge Eating Disorder Drug Growth Drivers
  • 9.3 Binge Eating Disorder Drug Market Challenges
  • 9.4 Binge Eating Disorder Drug Market Restraints

10 Global Market Forecast

  • 10.1 Binge Eating Disorder Drug Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Binge Eating Disorder Drug by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Binge Eating Disorder Drug by Type (2022-2027)
  • 10.2 Binge Eating Disorder Drug Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Binge Eating Disorder Drug by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Binge Eating Disorder Drug by Application (2022-2027)
  • 10.3 Binge Eating Disorder Drug Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Binge Eating Disorder Drug by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Binge Eating Disorder Drug by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Antidepressants
    Anticonvulsants
    Anti-obesity Medications

    Segment by Application
    Retail Pharmacies
    Hospital Pharmacies
    Online Pharmacies

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Roche
    Chronos Therapeutics
    Heptares
    Novo Nordisk
    Omeros Corp
    Sunovion Pharmaceuticals
    Opiant Pharmaceuticals

    Buy now